Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
11 October, 2015 01:14 IST
Nifty has strong resistances at 5,610/5,640/5,670: Moses Harding
Source: IRIS | 19 Nov, 2012, 08.04AM
Comments  |  Post Comment

Nifty fell sharply from intra-week resistance window of 5,750-5,780 to hit set buy zone of 5,610-5,580 for further extension into 5,559 before close of week at 5,574. Market Pulse considered 5,610-5,580 as good re-entry point after chasing 150 point rally from 5,630-5,580 into 5,780-5,830. The immediate term outlook is weak as weekly close below 5,580 will take bulls out of the street. The global bourses also do not provide support driven by uncertainties in the US and Euro zones. The domestic cues are worse, hence may need to allow deeper correction for better value buying. It is important for Nifty to get back into familiar trading range of 5,580-5,780 to knock out bearish momentum.

Commenting on the outlook for equity market, Moses Harding, Head - ALCO and Economic & Market Research, IndusInd Bank said, “The immediate support is at 5,568-5,559; test/break here will quickly extend weakness into 5,510-5,475 where it is good for strategic players to buy the second lot holding the final lot for 5,415-5,400 with stop on break here. There are strong resistances at 5,610/5,640/5,670 which should hold to retain bearish undertone into 5,400.”

“For the week, let us watch 5,510-5,610 with extension limited to 5,475-5,640. The strategy for traders is to sell at 5,610-5,640 and buy at 5,510-5,475 with tight stop on break thereof,” he said.

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Related Articles
TCI board approves demerger of subsidiary - 09-Oct-2015 19:25
Tata Motors to invest USD 2 bn in Slovak Republic - 09-Oct-2015 19:01
Suprajit Engineering acquires balance 10.88% stake in Phoenix Lamps - 09-Oct-2015 16:56
Analysts see sequential rise in Infosys Q2 earnings - 09-Oct-2015 14:57
Unichem Labs gets USFDA nod for Montelukast Sodium tablets - 09-Oct-2015 14:56
IndusInd Bank Q2 profit climbs 30% - 09-Oct-2015 14:32
Aurobindo gets USFDA nod for Aripiprazole tablets - 09-Oct-2015 13:02
Cairn India's production rises 1% in H1FY16 - 09-Oct-2015 12:57
FIIs, DIIs reduce stake in Thermax in Sept quarter - 09-Oct-2015 12:38
Reliance Sec recommends 'Buy' on Persistent Systems; target Rs 875 - 09-Oct-2015 12:04
FIIs, DIIs raise stake in Crompton Greaves in September quarter - 09-Oct-2015 11:53
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer